Chicago paper publishes AI-generated 'summer reading list' with books that don't exist
On Sunday, the publication released a special 64-page section titled "Heat Index: Your Guide to the Best of Summer" which featured a list of 15 recommended books for summer. However, upon further look, it was found that 10 of the 15 books on the list were not real.
One example included a book called "Nightshade Market" by Min Jin Lee, which was described as a "riveting tale set in Seoul's underground economy" and follows "three women whose paths intersect in an illegal night market" exploring "class, gender and the shadow economies beneath prosperous societies."
Lee herself confirmed on her X account on Tuesday that the book was not real.
'Heart Wrenching': Ai Expert Details Dangers Of Deepfakes And Tools To Detect Manipulated Content
"I have not written and will not be writing a novel called 'Nightshade Market.' Thank you," Lee wrote.
Read On The Fox News App
Chicago Public Media CEO Melissa Bell remarked on the situation in an article on Tuesday, revealing that the mistake came from a freelance writer from one of their partner companies, King Features. Bell acknowledged that the list was published without review from the editorial team.
"We are in a moment of great transformation in journalism and technology, and at the same time, our industry continues to be besieged by business challenges," Bell wrote. "This should be a learning moment for all journalism organizations: Our work is valued — and valuable — because of the humanity behind it."
Moving forward, Bell announced that the paper will be reviewing its relationship with content partners like King Features, updating its policies for third-party content and explicitly identifying third-party content in its publications. The Chicago Sun-Times also removed the section from its e-paper version and confirmed that it would not charge subscribers who bought the premium edition.
"We are committed to making sure this never happens again. We know that there is work to be done to provide more answers and transparency around the production and publication of this section, and will share additional updates in the coming days," Bell said.
In another report for the Chicago Sun-Times, the freelance writer was identified as Marco Buscaglia, who confirmed that he used AI for this and other stories without disclosing it to supervisors or fully vetting the results.
Ai Could Be 'Nail In The Coffin' For The Internet, Warns Neil Degrasse Tyson
King Features later added that it was "terminating" its relationship with Buscaglia, saying that he had violated strict policy regarding the use of AI.
In an additional statement to Fox News Digital on Wednesday, Chicago Public Media marketing director Victor Lim said, "Regarding Chicago Public Media's usage of generative AI, we are committed to producing journalism that is accurate, ethical, and deeply human. While GAI may assist with certain tasks—like summarizing documents or analyzing data—our editorial content will always be created and shaped by journalists."Original article source: Chicago paper publishes AI-generated 'summer reading list' with books that don't exist
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
What Canadian National Railway (TSX:CNR)'s Reduced Earnings Guidance Means For Shareholders
Earlier this month, Canadian National Railway faced ongoing operational challenges and reported that its expected business turnaround had not materialized, leading to reduced earnings growth guidance. This setback has sparked negative sentiment, with some industry observers drawing comparisons to competitors viewed as better positioned for growth and highlighting alternatives within the sector. With reduced earnings growth guidance in focus, we'll explore how these operational issues may shift Canadian National Railway's investment narrative. AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Canadian National Railway Investment Narrative Recap To be a shareholder in Canadian National Railway, you need confidence in the company's ability to capitalize on long-term shifts toward intermodal and bulk transport as industries focus on supply chain resilience and North American trade. However, the recent reduction in earnings growth guidance directly impacts the key short-term catalyst, an expected business turnaround, and highlights concerns around volume growth, currently the most prominent risk for the business. The news meaningfully shifts investor attention from network advantages to near-term operational execution. Among recent announcements, the second-quarter results stand out. While CN grew net income and earnings per share compared to the prior year, sales have edged lower, reflecting the ongoing volume and demand pressures underpinning the news event. This reinforces the theme that even targeted capital spending and cost discipline will take time to translate into renewed growth, particularly if market conditions stay challenging. In contrast, investors should also be aware that structural shifts in customer routing and industry competitiveness could... Read the full narrative on Canadian National Railway (it's free!) Canadian National Railway's narrative projects CA$19.6 billion revenue and CA$5.6 billion earnings by 2028. This requires 4.6% yearly revenue growth and a CA$1.0 billion earnings increase from CA$4.6 billion today. Uncover how Canadian National Railway's forecasts yield a CA$153.14 fair value, a 19% upside to its current price. Exploring Other Perspectives Simply Wall St Community members provided 12 fair value estimates for CNR ranging from CA$119.59 to CA$170.64 per share. These divergent opinions come as growth in shipping volumes remains a critical uncertainty for the company's ability to regain momentum, explore the range of forecasts and viewpoints from across the Community. Explore 12 other fair value estimates on Canadian National Railway - why the stock might be worth 7% less than the current price! Build Your Own Canadian National Railway Narrative Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your Canadian National Railway research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision. Our free Canadian National Railway research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Canadian National Railway's overall financial health at a glance. Want Some Alternatives? Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay: Outshine the giants: these 19 early-stage AI stocks could fund your retirement. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 28 companies in the world exploring or producing it. Find the list for free. Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
an hour ago
- CNBC
Qantas to pay record fine of $58 million for pandemic sackings criticized by judge
A court ordered Australia's largest airline, Qantas Airways, on Monday to pay a record fine of A$90 million ($58.64 million) for illegally sacking 1,800 ground staff during the COVID-19 pandemic and criticized it for a lack of contrition. In imposing the penalty, the largest ordered by a court on a company in the history of Australia's labor laws, Federal Court Judge Michael Lee also inveighed against the airline's litigation strategy. While Qantas made changes to its board and management team, Lee said subsequent expressions of regret seemed more aligned with "the damage" the case had done to the company than remorse for the harm caused to workers. "I accept Qantas is sorry, but I am unconvinced that this measure of regret is not, at least in significant measure ... the wrong kind of sorry," he added. Lee said the size of the penalty, about 75% of the maximum he could have set, was important to ensure it "could not be perceived as anything like the cost of doing business". He said A$50 million of the fine would be paid to the Transport Workers' Union, which brought the case against Qantas. After the decision, Michael Kaine, the national secretary of the TWU, said, "Against all the odds, we took on a behemoth ... that had shown itself to be ruthless, and we won." Monday's decision follows a December agreement on a compensation fund of A$120 million struck by the airline and the sacked workers. During the pandemic in 2020, Qantas' senior management decided to lay off 1,820 ground staff and shift their work to contractors. Qantas said it was a commercial decision, but the Federal Court in 2021 held the move to be "adverse action", preventing staff from exercising their workplace rights and unionising, in breach of Australia's Fair Work Act. Assessing Qantas' actions, Lee said he was unconvinced it was truly contrite and criticized its culture, public relations approach and litigation strategy. For example, he said Qantas had announced it would appeal to the High Court against the 2021 court decision "without any time passing", to consider the 431-paragraph judgment. When its appeal failed, Qantas issued a statement "spinning" the outcome, however, and overlooking findings on its unlawful conduct, he added. He also criticized Qantas' conduct during litigation, such as opting to keep out of the witness box, Vanessa Hudson, its current chief executive and former chief financial officer. "It is one thing for the 'Qantas News Room' to issue press releases by a CEO saying sorry; it is quite another for written assertions of contrition, recognition of wrong and cultural change to be tested in a courtroom," Lee said. The penalty was the largest ever ordered by a court for violations of Australia's labor laws, said Maurice Blackburn Lawyers, which represented TWU. "This record-breaking penalty reflects the monumental scale of Qantas' wrongdoing," the firm's principal, Josh Bornstein, said in a statement. The fine also reflected the unprecedented finding of adverse action against so many workers, said Shae McCrystal, a labor law professor at the University of Sydney. "Adverse action cases are risky," she said. "It signals a message to employers that if they break the law, then trade unions may receive those penalties in order to assist them in enforcing the act." Qantas said it would pay the fine as ordered. "We sincerely apologise to each and every one of the 1,820 ground handling employees and to their families," Chief Executive Vanessa Hudson said in a statement. Qantas shares were down 0.4% at A$11.58 in early trading.
Yahoo
an hour ago
- Yahoo
Arvinas, Pfizer's Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment
Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc. (NYSE:PFE), announced that the US FDA accepted its New Drug Application/NDA for vepdegestrant. The drug is intended to treat patients with estrogen receptor-positive/ER+, human epidermal growth factor receptor 2-negative/HER2-, ESR1-mutated advanced or metastatic breast cancer who have already received endocrine-based therapy. The FDA has set a Prescription Drug User Fee Act/PDUFA action date of June 5, 2026. The NDA is based on data from the Phase 3 VERITAC-2 clinical trial, which showed a statistically significant and clinically meaningful improvement in median progression-free survival for vepdegestrant compared to fulvestrant. The trial enrolled 624 patients at 213 sites across 25 countries, with 270 of these patients having the ESR1 mutation. A biopharma executive in a meeting room discussing the clinical-stage of a new therapy. The results from this trial were recently presented at the American Society of Clinical Oncology/ASCO 2025 Annual Meeting and published in The New England Journal of Medicine. Vepdegestrant is an investigational oral drug that functions as a PROteolysis TArgeting Chimera/PROTAC estrogen receptor degrader. This marks the first time a PROTAC has demonstrated a clinical benefit in breast cancer patients. Arvinas Inc. (NASDAQ:ARVN) is a clinical-stage biotechnology company that engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally. While we acknowledge the potential of ARVN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
